Asahi Pharma Co., Ltd.
PrivateLast Round
VC Round
Oct 23, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Asahi Pharma Co., Ltd. is a biotechnology company that conducts research and development of novel small-molecule therapeutics for xerostomia (dry mouth).
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Asahi Pharma Co., Ltd. Comparables
Compare Asahi Pharma Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lubris BioPharma | 77% | |
| Eagle Pharmaceuticals, Inc. | 75% | |
| Daiichi Sankyo | 69% | |
Asahi Pharma Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 23, 2025 |
Asahi Pharma Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tohoku University Venture Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 23, 2025
$660K round led by Tohoku University Venture Partners.
Asahi Pharma Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Asahi Pharma Co., Ltd.'s valuation, stock price, and market status.